Thank you, Mr. Chair.
Thank you, witnesses, for your testimony.
This bill is an interesting bill. I'm going to say right off that I'm intrigued by the drug treatment courts, DTC, aspect of the bill. A large part of my questioning will be on that.
First of all, Mr. Plecas, you mentioned that you had studies. Have they been tabled? You touched on some studies.